Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

ERISA Recap: 6 Things Attys May Have Missed In Oct. No Photo Available

Kellie Mejdrich

Two appeals court judges used a decision in an employee stock ownership plan case to urge the full Eleventh Circuit to rethink its req... (more story)

Judges Wade Into Abortion Pill Access And Rx Pricing Fights No Photo Available

Hannah Albarazi

In a flurry of recent legal activity, courts across the country have been drawn into the nation's most contentious healthcare debates ... (more story)

Defining The 'Superior' Bid In Pfizer-Novo Legal Battle No Photo Available

Yeji Jesse Lee

Pfizer and Novo Nordisk's bidding war and legal fight over obesity biotech company Metsera is raising questions around what legally co... (more story)